EANS-News: Henkel AG & Co. KGaA / Henkel reports solid start to fiscal 2011
Geschrieben am 04-05-2011 |
--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------
quarterly report/3-month report/Henkel
Düsseldorf (euro adhoc) - May 4, 2011
Henkel expects stronger organic sales growth
Henkel reports solid start to fiscal 2011
• Sales increase of 8.9 percent to 3,823 million euros (organic: +7.2%)
• Adjusted* operating profit: plus 12.1 percent to 473 million euros
• Adjusted* EBIT margin: plus 0.4 percentage points to 12.4 percent
• Adjusted* earnings per preferred share (EPS): plus 21.7 percent to 0.73
euros
• Growth regions continue to post above-average increases (+14.8 percent)
• Market environment characterized by rising raw material prices and intense
competition
Düsseldorf, Germany - "Despite the challenging market
environment, Henkel reports a solid start to the financial year.
We achieved very good organic sales growth, once again
outperforming our relevant markets," said Henkel CEO Kasper
Rorsted. "All our business sectors contributed to this success and
with continued double-digit growth rates we were able to further
expand our position in the emerging markets. We are fully committed
to our strategic priorities and remain confident of being able to
achieve our 2012 targets."
For the fiscal year 2011, Rorsted provided the following
guidance: "With intense competition and rising raw material costs,
the economic environment will remain challenging. We will need to
continue reviewing our structures to ensure our long-term
international competitiveness." Henkel has slightly raised its
expectations for organic sales growth: "We are confident that we will
again outperform our relevant markets in 2011 and now expect an
increase in organic sales at the upper end of the 3 to 5 percent
range. We expect - in line with our previous guidance -
increasing our adjusted EBIT margin to around 13 percent and
improving adjusted earnings per preferred share by about 10
percent," Rorsted added.
Henkel´s sales in the first quarter of 2011 came in at 3,823 million
euros, an increase of 8.9 percent compared to the figure for the
prior-year quarter. After adjusting for foreign exchange, sales
improved by 6.8 percent. At 7.2 percent, organic sales - that is
to say sales adjusted for foreign exchange and
acquisitions/divestments - again increased significantly. This
positive development was supported by all Henkel business sectors.
Due in particular to strong volume increases, Laundry & Home Care
generated growth of 1.6 percent. With organic sales growth of 5.7
percent, the Cosmetics/Toiletries business sector outstripped a
very strong prior- year quarter and again significantly exceeded
growth in the relevant markets. With both price and volume
driven organic growth of 11.5 percent, Adhesive Technologies
significantly outstripped an already strong prior-year quarter. As a
result, Henkel further expanded its global market shares in all
three business sectors.
After allowing for one-time gains, one-time charges and
restructuring charges, adjusted operating profit improved by 12.1
percent, from 421 million euros to 473 million euros. Operating
profit (EBIT) increased by 1.9 percent, from 422 million euros to
430 million euros.
Adjusted return on sales (EBIT margin) grew by 0.4 percentage points,
from 12.0 percent to 12.4 percent. Return on sales came in at 11.2
percent following 12.0 percent in the prior-year period.
Financial result improved from -54 million euros to -37 million
euros due to lower net debt and an increased balance arising
from currency hedging activities. The tax rate was 26.2 percent
(prior-year quarter: 27.7 percent).
Net income for the quarter rose by 9.0 percent, from 266 million
euros to 290 million euros. After deducting non-controlling
interests totaling 7 million euros, net income for the quarter
came in at 285 million euros (prior-year quarter: 259 million
euros). Adjusted net income for the quarter after non-
controlling interests increased by an appreciable 20.4 percent,
from 265 million euros to 319 million euros. Earnings per
preferred share (EPS) rose from 0.60 euros to 0.66 euros. The
adjusted figure was 0.73 euros compared to 0.60 euros in the
prior-year quarter.
Once again, good progress was also made in the management of
net working capital. Compared to the prior-year period, the ratio of
net working capital to sales improved by 0.6 percentage points to
7.9 percent. Net debt was reduced to 2.1 billion euros.
Business sector performance
Despite the continuing intensity of the competitive environment, the
Laundry & Home Care business sector increased nominal sales by
2.2 percent to 1,072 million euros. Organically, sales rose by 1.6
percent, supported primarily by strong volume growth of 4.8
percent against a downturn in pricing levels.
Regional development was very mixed. Eastern Europe posted high
organic growth, as did Latin America, the latter due in particular
to the launch of Persil in Mexico. Growth rates in the
Africa/Middle East region were lower than in past periods as a
result of political unrest in some of the countries of importance
to Henkel. However, the situation improved substantially toward the
end of the quarter. In North America, sales decreased due to
declining markets and persistently strong competitive pressures.
By contrast, Western Europe registered a significant
improvement in sales, driven in particular by strong growth in
Germany and France. This resulted in a further increase in
market share in Western Europe.
Operating profit totaled 100 million euros, compared to 151 million
euros in the prior-year quarter, with the restructuring charges
incurred for further production site optimization having a
particular impact. Due to increased material costs and a decline
in selling price levels, adjusted operating profit at 133 million
euros and adjusted return on sales at 12.4 percent also remained
slightly below the levels of the first quarter 2010.
Cosmetics/Toiletries started with a very strong quarter to fiscal
2011. Sales exceeded the already strong prior-year period by 7.7
percent and reached 821 million euros. In organic terms, sales
increased by 5.7 percent and was once more well above that of the
relevant markets. This successful development was due to the
consistent pursuance of the business sector´s innovation offensive
with numerous new product launches.
All regions and businesses contributed to this growth. Eastern
Europe, Latin America and Asia´s emerging markets achieved again
double-digit growth rates. Western Europe and North America
likewise made a very good start to the year. Due to successful
innovations sales in both regions were significantly increased
and market shares expanded.
Operating profit rose by 12.6 percent to 112 million euros. Adjusted
operating profit increased by even 15.1 percent to 113 million euros.
Adjusted return on sales improved by 0.9 percentage points,
reaching a new high for a first quarter of 13.8 percent.
The Adhesive Technologies business sector continued to drive
dynamic growth through the first quarter of 2011, posting a
substantial increase in sales of 14.1 percent to a total of
1,884 million euros. Organic growth, achieved through
appreciable volume increases accompanied by a rise in selling
prices, reached 11.5 percent, significantly exceeding market
development.
All regions and businesses contributed to this positive
performance. Once again, the emerging markets added particular
momentum, with Eastern Europe, Africa/Middle East and Asia
registering the highest rates of increase. However, substantial
sales growth was also achieved in the mature markets.
Although the rising raw material and packaging prices had a
significant negative impact, operating profit rose versus the
prior-year quarter by 31.6 percent to 244 million euros, with
efficiency enhancement measures and selling price rises more than
offsetting cost increases. Adjusted operating profit also underwent
a disproportionate rise of 22.6 percent to 247 million
euros. Adjusted return on sales improved by 0.9 percentage points to
13.1 percent.
Regional performance
In the Western Europe region, sales grew by 6.0 percent to 1,433
million euros, while the organic improvement was 5.1 percent. This
growth was supported by all the business sectors. Sales in
the Eastern Europe region increased substantially, by 14.3
percent to 656 million euros. Organic growth here came in at 13.2
percent, with double-digit percentage increases being posted by the
Cosmetics/Toiletries and Adhesive Technologies business
sectors. The Africa/Middle East region realized sales growth of 4.6
percent to 222 million euros. Organically, sales rose by 4.9
percent, supported in particular by Adhesive Technologies and
Cosmetics/Toiletries. Business performance in the region was
impacted by the political unrest in some of its countries, which had
a negative effect of around 20 million euros on sales. Sales in
the North America region rose by 4.7 percent to 676 million euros.
Organic sales growth amounted to 3.6 percent thanks to the results
achieved by Adhesive Technologies and Cosmetics/Toiletries, while
sales of the Laundry & Home Care business sector decreased
compared to the prior-year quarter. The Latin America region
continued to perform very well, recording a sales increase of 17.1
percent to 253 million euros. Organic sales growth came in at 10.1
percent, with all the business sectors contributing. The
Asia-Pacific region registered strong sales growth of 16.2 percent
to 536 million euros. In organic terms, sales rose by 10.8
percent, supported in particular by developments at the
Adhesive Technologies business sector. In the growth regions of
Eastern Europe, Africa/Middle East, Latin America and Asia
(excluding Japan), sales rose by 14.8 percent to 1,537 million
euros. Organic growth amounted to 12.4 percent, keeping it in
the double-digit percentage range. The increase was especially
supported by higher sales generated by Adhesive Technologies and
Cosmetics/Toiletries. The share of sales attributable to the
growth regions increased from 38 percent in the prior- year quarter
to 40 percent this time.
Sales and profits forecast 2011
Following a solid first quarter, Henkel is confident of again
outperforming its relevant markets in terms of organic sales
growth. Henkel now expects an increase in organic sales at the
upper end of (previously: "within") the range of 3 to 5 percent.
Henkel confirms its forecast for an adjusted return on sales (EBIT)
of around 13 percent (2010: 12.3 percent) and an increase in
adjusted earnings per preferred share of around 10 percent. Henkel
bases this guidance on anticipated increases of its selling prices
and the ongoing adaptation of its structures to the constantly
changing market conditions. Through these activities and the
maintenance of its strict cost discipline, Henkel intends to more
than offset the effects of further rising raw material costs
on its earnings.
This document contains forward-looking statements which are
based on the current estimates and assumptions made by the
corporate management of Henkel AG & Co. KGaA. Forward-looking
statements are characterized by the use of words such as expect,
intend, plan, predict, assume, believe, estimate, anticipate and
similar formulations. Such statements are not to be understood as
in any way guaranteeing that those expectations will turn out to be
accurate. Future performance and the results actually achieved by
Henkel AG & Co. KGaA and its affiliated companies depend on a
number of risks and uncertainties and may therefore differ
materially from the forward-looking statements. Many of these
factors are outside Henkel´s control and cannot be accurately
estimated in advance, such as the future economic environment and
the actions of competitors and others involved in the marketplace.
Henkel neither plans nor undertakes to update forward-looking
statements.
Contact
Lars Witteck Wulf Klüppelholz
Tel. +49 211 797 - 2606 Tel. +49 211 797 - 1875
Fax +49 211 798 - 4040 Fax +49 211 798 - 4040
Henkel AG & Co. KGaA
The report for the first quarter of 2011 and other information with download
material and the link to the teleconference broadcast can be found in our press
folder on the internet at:
http://www.henkel.com/press/publication-report-q1- 2011-32284.htm
press@henkel.com
end of announcement euro adhoc
--------------------------------------------------------------------------------
ots Originaltext: Henkel AG & Co. KGaA
Im Internet recherchierbar: http://www.presseportal.de
Further inquiry note:
Irene Honisch
Tel.: +49 (0)211 797-5668
E-Mail: irene.honisch@henkel.com
Branche: Consumer Goods
ISIN: DE0006048432
WKN: 604843
Index: DAX, CDAX, HDAX, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade
Berlin / regulated dealing
Kontaktinformationen:
Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.
Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.
Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.
http://www.bankkaufmann.com/topics.html
Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.
@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf
E-Mail: media(at)at-symbol.de
329639
weitere Artikel:
- EANS-Adhoc: Intercell AG / Intercell starts clinical trial in Pandemic Influenza
with its Vaccine Enhancement Patch and provides update to the strategic
collaboration with GSK on patches --------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------
Research & Development
04.05.2011
» Intercell starts a confirmatory clinical study using the Vaccine
Enhancement Patch in combination with GSK's H5N1 pandemic
Influenza antigen » GSK and Intercell underline mehr...
- EANS-Adhoc: Intercell AG / Intercell startet klinische Studie für das
immunstimmulierende Impfpflaster gegen pandemische Grippe und berichtet über
aktuellen Stand der strategischen Allianz mit GSK im --------------------------------------------------------------------------------
Ad-hoc-Mitteilung übermittelt durch euro adhoc mit dem Ziel einer
europaweiten Verbreitung. Für den Inhalt ist der Emittent verantwortlich.
--------------------------------------------------------------------------------
Forschung/Entwicklung
04.05.2011
» Intercell startet eine bestätigende, klinische Studie des
immunstimmulierenden Impfpflasters "Vaccine Enhancement Patch" (VEP)
in Kombination mit dem pandemischen Influenza Antigen H5N1 von mehr...
- EANS-News: Henkel AG & Co. KGaA / Henkel startet gut in das Geschäftsjahr 2011 --------------------------------------------------------------------------------
Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der
Emittent/Meldungsgeber verantwortlich.
--------------------------------------------------------------------------------
Geschäftszahlen/Bilanz/Quartalsbericht/Unternehmen/3-Monatsbericht/He
nkel
Düsseldorf (euro adhoc) - Henkel erwartet stärkeres organisches
Umsatzwachstum
Henkel startet gut in das Geschäftsjahr 2011
• Umsatzsteigerung von 8,9 Prozent auf 3.823 Mio. Euro mehr...
- EANS-News: Agennix AG berichtet über den Geschäftsverlauf im Ersten Quartal 2011 Highlights des Quartals: Abschluss der Patientenaufnahme in Phase
III-Studie FORTIS-M und Erhalt eines wichtigen US-Patents für
Talactoferrin
--------------------------------------------------------------------------------
Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der
Emittent/Meldungsgeber verantwortlich.
--------------------------------------------------------------------------------
Quartalsbericht
Utl.: Highlights des Quartals: Abschluss der Patientenaufnahme in
Phase III-Studie FORTIS-M und Erhalt mehr...
- EANS-News: Agennix AG Reports Financial Results for First Quarter of 2011 Quarter highlighted by completion of enrollment in talactoferrin
Phase III FORTIS-M trial and issuance of key U.S. patent for
talactoferrin in oncology
--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------
quarterly report
Subtitle: Quarter highlighted by completion of enrollment in
talactoferrin mehr...
|
|
|
Mehr zu dem Thema Finanzen
Der meistgelesene Artikel zu dem Thema:
Century Casinos wurde in Russell 2000 Index aufgenommen
durchschnittliche Punktzahl: 0 Stimmen: 0
|